Simvastatin but not bezafibrate decreases plasma lipoprotein-associated phospholipase A2 mass in type 2 diabetes mellitus: Relevance of high sensitive C-reactive protein, lipoprotein profile and low-density lipoprotein (LDL) electronegativity
Alexander Constantinides, Rindert de Vries, Jeroen J.J. van Leeuwen, Thomas Gautier, L. Joost van Pelt, Alexandros D. Tselepis, Laurent Lagrost, Robin P.F. DullaartТом:
23
Рік:
2012
Мова:
english
DOI:
10.1016/j.ejim.2012.05.008
Файл:
PDF, 383 KB
english, 2012